High-Dose Radiotherapy for the Treatment of Inoperable Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

High-Dose Radiotherapy for the Treatment of Inoperable Non–Small Cell Lung Cancer

Published:2007-07 Issue:4 Volume:13 Page:238-242
ISSN:1528-9117
Container-title:The Cancer Journal
language:en
Short-container-title:

Author:

Sura Sonal,Yorke Ellen,Jackson Andrew,Rosenzweig Kenneth E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference25 articles.

1. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.;Gajra;Lung Cancer,2003

2. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410.;Curran;Proc Am Soc Clin Oncol,2003

3. The role of radiotherapy in treatment of stage I non-small cell lung cancer.;Qiao;Lung Cancer,2003

4. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer.;Armstrong;Int J Radiat Oncol Biol Phys,1993

5. Long-term observations of the patterns of failure with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy.;Perez;Cancer,1987

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors;Advances in Radiation Oncology;2023-11

2. Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer;Biomedicine & Pharmacotherapy;2022-11

3. Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports;Cureus;2022-04-09

4. Lattice radiation therapy – its concept and impact in the immunomodulation cancer treatment era;Revista da Associação Médica Brasileira;2020-06

5. Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non–small-cell lung cancer;Journal of Radiation Research;2019-04-11